Potential role of pimecrolimus as maintenance therapy for atopic dermatitis

被引:0
|
作者
Eichenfield, L
Leung, DYM
机构
[1] Univ Calif San Diego, Childrens Hosp, San Diego, CA 92103 USA
[2] Univ Calif San Diego, Ctr Hlth, San Diego, CA 92103 USA
[3] Natl Jewish Med & Res Ctr, Denver, CO USA
关键词
D O I
10.1016/S0091-6749(02)81917-0
中图分类号
R392 [医学免疫学];
学科分类号
100102 ;
摘要
782
引用
收藏
页码:S256 / S256
页数:1
相关论文
共 50 条
  • [21] Pimecrolimus but not corticosteroid improves the skin barrier in atopic dermatitis
    Proksch, E.
    Jensen, J.
    Braeutigam, M.
    Schwarz, T.
    Foelster-Holsi, R.
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2008, 128 : S104 - S104
  • [22] Pimecrolimus for the Treatment of Atopic Dermatitis in Infants: An Asian Perspective
    Chia-Yu Chu
    Tsung-Chieh Yao
    I.-Hsin Shih
    Chin-Yi Yang
    Chan Lee Chin
    Sabeera Begum Binti Kader Ibrahim
    Suganthi Thevarajah
    Leong Kin Fon
    Marco Hok-Kung Ho
    Chow Chung Mo
    Chow Pok Yu
    Steven King-Fan Loo
    Thomas Luger
    Dermatology and Therapy, 2023, 13 : 717 - 727
  • [23] The effects of pimecrolimus on the innate immune response in atopic dermatitis
    Danby, S. G.
    Cork, M. J.
    BRITISH JOURNAL OF DERMATOLOGY, 2013, 168 (02) : 235 - 236
  • [24] Cost effectiveness of pimecrolimus (elidel) in the treatment of children with atopic dermatitis
    Grueger, J
    van Assche, D
    VALUE IN HEALTH, 2002, 5 (06) : 556 - 556
  • [25] Use of pimecrolimus cream in disorders other than atopic dermatitis
    Day, Isaiah
    Lin, Andrew N.
    JOURNAL OF CUTANEOUS MEDICINE AND SURGERY, 2008, 12 (01) : 17 - 26
  • [26] Pimecrolimus but not betamethasone preserves antimicrobial protein expression in atopic dermatitis
    Jensen, J. M.
    Koehler, B.
    Harder, J.
    Braeutigam, M.
    Schwarz, T.
    Foelster-Holst, R.
    Proksch, E.
    Glaeser, R.
    EXPERIMENTAL DERMATOLOGY, 2008, 17 (03) : 268 - 268
  • [27] Topical pimecrolimus for skin other disease than atopic dermatitis
    Wollina, Uwe
    Hansel, Gesina
    Koch, Andre
    Abdel-Naser, Mohamed Badawy
    EXPERT OPINION ON PHARMACOTHERAPY, 2006, 7 (14) : 1967 - 1975
  • [28] The topical calcineurin inhibitor pimecrolimus in atopic dermatitis: a safety update
    Thaci, D.
    Salgo, R.
    ACTA DERMATOVENEROLOGICA ALPINA PANNONICA ET ADRIATICA, 2007, 16 (02): : 58 - 62
  • [29] Topical use of pimecrolimus in atopic dermatitis: Update on the safety and efficacy
    Werfel, Thomas
    JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, 2009, 7 (09): : 739 - 743
  • [30] Potential Role of Endothelin-1 in Atopic Dermatitis
    Takeshi Nakahara
    Makiko Kido-Nakahara
    Masutaka Furue
    Current Treatment Options in Allergy, 2019, 6 : 156 - 163